Increased abundance and activity of the enzyme is associated with AD in the general population [15–17], particularly with the accumulation of amyloid-β within the brain [18], and variation in the CTSB (CatB gene) is associated with the risk of late-onset AD [19]. The gene discussed is CTSB; the disease is Alzheimer disease.